Company intelligence / Profile preview

Inari Medical

Irvine, California, United Statesinarimedical.com ↗

Ownership: Public · NARI
Employees: ~1000
Development stage: Commercial

Overview

Inari Medical has pioneered and commercialized a suite of mechanical thrombectomy devices for the removal of blood clots in patients with venous diseases. Their products are FDA-cleared and have demonstrated strong clinical outcomes for treating PE and DVT. The company has robust revenue growth, gross margins over 80%, and its technologies are supported by peer-reviewed literature documenting improved patient outcomes[3][5].

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Drug pipeline

4 assets

FlowTriever

Commercial

Indications: Pulmonary Embolism

3 more assets in the full pipeline.

Request access →

Partnerships

Gilde Healthcare

Financials

Market cap: $4.7B
Total revenue: $153.4M
Enterprise value: $4.6B

Beyond the preview

Go deeper on Inari Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inari Medical.

Explore the full profile